Role Of Brain Serotonin In Animal Models Of Schizophrenia
Funder
National Health and Medical Research Council
Funding Amount
$175,550.00
Summary
There is increasing evidence that deficiencies in the release of a brain chemical called serotonin play an important role in the development of schizophrenia. Post-mortem studies have shown changes in the levels of 'receptors' (keyholes for messenger chemicals in the brain) for serotonin in schizophrenia. In addition, in the treatment of schizophrenia, the more recently introduced 'atypical' antipsychotic drugs are superior to the more traditional 'typical' antipsychotics in terms of efficacy an ....There is increasing evidence that deficiencies in the release of a brain chemical called serotonin play an important role in the development of schizophrenia. Post-mortem studies have shown changes in the levels of 'receptors' (keyholes for messenger chemicals in the brain) for serotonin in schizophrenia. In addition, in the treatment of schizophrenia, the more recently introduced 'atypical' antipsychotic drugs are superior to the more traditional 'typical' antipsychotics in terms of efficacy and side-effect profile. Typical antipsychotic drugs act mainly through blockade of receptors for a brain chemical called dopamine. Atypical drugs appear to have additional actions, in particular blocking the effect of serotonin in the brain. This evidence is mostly circumstancial, relying to a large extent on biochemical analysis of brain regions and 'receptors' on which antipsychotics MAY act. It is currently unclear exactly how and where in the brain changes in serotonin activity influence behavioural processes causing schizophrenia. It is also unclear how and where typical and atypical antipsychotic drugs interact with the role of serotonin in schizophrenia. In this project we intend to inactivate specific parts of the serotonin system of otherwise intact, freely moving rats. Using behavioural observation methods relevant for schizophrenia, we will analyze if and how these interventions influence the behaviour of these rats. The results can have important implications for our fundamental understanding of the involvement of serotonin in the brain in schizophrenia.Read moreRead less
Dopamine Mechanisms Conferring Resilience To Depression: A New Antidepressant Target
Funder
National Health and Medical Research Council
Funding Amount
$560,948.00
Summary
A significant proportion of people who suffer depression fail to obtain effective relief from either drugs or psychotherapy. Accordingly, there is a pressing need to develop new, and more effective, treatments. This project will determine whether certain specific brain pathways that use the transmitter dopamine can be manipulated in their activity so as to increase resilience to depression. This work has potential to provide the foundation for the development a new generation of antidepressants.
The Neurochemical Basis Of Behavioural Control: Relevance For Addiction, OCD And Tourette Syndrome.
Funder
National Health and Medical Research Council
Funding Amount
$375,225.00
Summary
Both the control of voluntry responses over reflexive habits, and the ability to direct voluntary responses appropriately when there are conflicting choices present in the world, are thought to be important in mental disorders such as drug addiction, tic disorders such as Tourette syndrome and obsessive compulsive disorder. This project will examine the brain neurochemistry that underpins our ability to control voluntary responses, providing insight into potential pharmacological interventions.